MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Characterizing levodopa-induced dyskinesias using multimodal neuroimaging, clinical and behavioral measures

S. Shukla, S. Tinaz, N. Thirugnanasambandam (Mumbai, India)

Meeting: 2024 International Congress

Abstract Number: 1073

Keywords: Levodopa(L-dopa), Magnetic resonance imaging(MRI), Parkinson’s

Category: Parkinson's Disease: Neuroimaging

Objective: Our objective is to investigate potential differential modulation in motor and executive function networks among patients with LID, and to explore its correlation with brain morphology, clinical characteristics and behavioral parameters. Employing such a multimodal approach will deepen our understanding of the pathophysiology of LID and enable identification of specific functional networks for targeted therapeutic neuromodulation.

Background: LID is a motor complication that arises after chronic dopaminergic therapy in over 40% of patients with PD. Studies have shown that patients with LID show distinct changes in brain morphology and resting state functional connectivity as compared to their non-dyskinetic counterparts.  However, there is lack of understanding of how task-specific cortico-subcortical networks are differentially modulated in these patient groups.

Method: We collected structural, resting-state and task-based functional MRI data from 17 DysPD patients, 15 nonDysPD patients, and 21 age- and sex-matched healthy subjects. Patients with mild to moderate PD (H&Y ≤ 3) and with unimpaired cognitive functioning (MoCA ≥ 24) were recruited. MRI was recorded on a 3T Siemens Magnetom Prisma scanner with a 64-channel head coil. The obtained structural T1-weighted data were processed using FreeSurfer v6 to extract volume, surface area and thickness measurements of subcortical and cortical regions. Region-based statistical analysis was performed using SPSS v29.

Results: All three groups were similar in age, sex and cognitive score. Volumetric analysis showed that DysPD patients had significantly larger cortical volume (p-corrected =0.0002) in the sensorimotor region compared to nonDysPD patients. However, cortical surface area and thickness were not significantly different across subject groups.

Conclusion: We found an increase in the cortical volume around the sensorimotor region of DysPD patients compared to the nonDysPD group. Such increased volume may indicate white matter inflammation with chronic dopaminergic therapy in dyskinesia. Next steps in our ongoing analyses involve examining the relationship of these structural differences with resting-state and task-specific functional brain networks. The findings of our research will shed light on the role of distinct task-specific functional brain networks in characterizing patients with LID and their relevance to novel therapeutic strategies.

Demographic and clinical characteristics.

Demographic and clinical characteristics.

Cortical volumetric analysis.

Cortical volumetric analysis.

To cite this abstract in AMA style:

S. Shukla, S. Tinaz, N. Thirugnanasambandam. Characterizing levodopa-induced dyskinesias using multimodal neuroimaging, clinical and behavioral measures [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/characterizing-levodopa-induced-dyskinesias-using-multimodal-neuroimaging-clinical-and-behavioral-measures/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/characterizing-levodopa-induced-dyskinesias-using-multimodal-neuroimaging-clinical-and-behavioral-measures/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley